Sulforaphane potentiates the efficacy of imatinib against chronic leukemia cancer stem cells through enhanced abrogation of Wnt/β-catenin function

Li Ching Lin, Chi-Tai Yeh, Chia Chun Kuo, Chi-Ming Lee, Gow Chin Yen, Liang Shun Wang, Chih Hsiung Wu, Wei Chung Vivian Yang, Alexander T H Wu

研究成果: 雜誌貢獻文章

34 引文 斯高帕斯(Scopus)

摘要

Sulforaphane (SFN) has been indicated for the prevention and suppression of tumorigenesis in solid tumors. Herein, we evaluated SFN's effects on imatinib (IM)-resistant leukemia stem cells (LSCs). CD34+/CD38- and CD34+/CD38+ LSCs were isolated from KU812 cell line flowcytometrically. Isolated LSCs showed high expression of Oct4, CD133, β-catenin, and Sox2 and IM resistance. Differentially, CD34 +/CD38- LSCs demonstrated higher BCR-ABL and β-catenin expression and imatinib (IM) resistance than CD34 +/CD38+ counterparts. IM and SFN combined treatment sensitized CD34+/CD38- LSCs and induced apoptosis, shown by increased caspase 3, PARP, and Bax while decreased Bcl-2 expression. Additionally, the combined treatment reduced BCR-ABL and β-catenin and MDR-1 protein expression. Mechanistically, IM and SFN combined treatment resensitized LSCs by inducing intracellular reactive oxygen species (ROS). Importantly, β-catenin-silenced LSCs exhibited reduced glutathione S-transferase pi 1 (GSTP1) expression and intracellular GSH level, which led to increased sensitivity toward IM and SFN. We demonstrated that IM and SFN combined treatment effectively eliminated CD34+/CD38- LSCs. Since SFN has been shown well tolerated in both animals and human, this regimen could be considered for clinical trials.
原文英語
頁(從 - 到)7031-7039
頁數9
期刊Journal of Agricultural and Food Chemistry
60
發行號28
DOIs
出版狀態已發佈 - 七月 18 2012

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Chemistry(all)

指紋 深入研究「Sulforaphane potentiates the efficacy of imatinib against chronic leukemia cancer stem cells through enhanced abrogation of Wnt/β-catenin function」主題。共同形成了獨特的指紋。

  • 引用此